These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 14889072)

  • 21. The genetic control of T cell-meditated immunity. I. Characterization of a mouse strain whose low responsiveness is inherited as a recessive trait.
    Vachek H; Kölsch E
    Immunology; 1974 Oct; 27(4):507-15. PubMed ID: 4215740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth characteristics of free tumor cells transferred serially in the peritoneal fluid of the mouse.
    GOLDIE H; FELIX MD
    Cancer Res; 1951 Feb; 11(2):73-80. PubMed ID: 14812430
    [No Abstract]   [Full Text] [Related]  

  • 23. A phase-contrast microscope study of free cells native to the peritoneal fluid of DBA/2 mice.
    FELIX MD; DALTON AJ
    J Natl Cancer Inst; 1955 Oct; 16(2):415-46. PubMed ID: 13263913
    [No Abstract]   [Full Text] [Related]  

  • 24. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
    Tempfer CB; Hilal Z; Dogan A; Petersen M; Rezniczek GA
    Eur J Surg Oncol; 2018 Jul; 44(7):1112-1117. PubMed ID: 29753612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Proliferation of cells in the peritoneal cavity. II. Proliferation of mesothelial cells, submesothelial connective tissue cells, endothelial cells, and peritoneal fluid cells induced by endotoxin].
    Mohr W; Beneke G; Murr L
    Beitr Pathol; 1972; 145(4):381-94. PubMed ID: 4259912
    [No Abstract]   [Full Text] [Related]  

  • 26. Jaundice associated with peritoneal absorption of bilirubin.
    Stathakos P; Fanska R; Carbone JV; Grodsky GM
    Gastroenterology; 1970 Nov; 59(5):769-78. PubMed ID: 5475137
    [No Abstract]   [Full Text] [Related]  

  • 27. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML; Parenza M; Parmiani G
    J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [THE DETERMINATION OF COLLOIDAL GOLD IN BIOLOGICAL MATERIAL BY NEUTRON ACTIVATION ANALYSIS. STUDIES ON SEVEN MALIGNANT PLEURAL OR PERITONEAL EFFUSION CASES WHO HAD HAD INTRACAVITARY INJECTION OF RADIOACTIVE COLLOIDAL GOLD].
    KATAKURA Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1964 Mar; 23():1531-7. PubMed ID: 14149274
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of macrophage-mediated cytolytic activity as a tumor suppressive mechanism during maintenance of the L5178Y-tumor dormant state in DBA/2 mice.
    Robinson MK; Wheelock EF
    J Immunol; 1981 Feb; 126(2):673-9. PubMed ID: 7451990
    [No Abstract]   [Full Text] [Related]  

  • 30. Distribution of IgM, IgA and IgG secreting cells in the tissues of normal and tumour-bearing mice.
    Howie S; McBride WH; James K
    Immunology; 1982 May; 46(1):43-8. PubMed ID: 7042550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Investigations on coeaction of the pleura in peritoneal stimulations].
    Mohr W; Beneke G; Murr L
    Pathol Microbiol (Basel); 1971; 37(6):459-68. PubMed ID: 5139302
    [No Abstract]   [Full Text] [Related]  

  • 32. The destruction of tumor cells by alloimmune peritoneal cells: mechanism of action of activated macrophages in vitro.
    Boyle MD; Ormerod MG
    J Reticuloendothel Soc; 1975 Feb; 17(2):73-83. PubMed ID: 804549
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer.
    Ozols RF; Locker GY; Doroshow JH; Grotzinger KR; Myers CE; Young RC
    Cancer Res; 1979 Aug; 39(8):3209-14. PubMed ID: 455305
    [No Abstract]   [Full Text] [Related]  

  • 34. [Teratocarcinoma of the mouse: isolation, culture and properties of pluripotential cells].
    Jakob H; Boon T; Gaillard J; Nicolas J; Jacob F
    Ann Microbiol (Paris); 1973 Oct; 124(3):269-82. PubMed ID: 4599372
    [No Abstract]   [Full Text] [Related]  

  • 35. Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells.
    Mikuła-Pietrasik J; Uruski P; Matuszkiewicz K; Szubert S; Moszyński R; Szpurek D; Sajdak S; Tykarski A; Książek K
    Cell Oncol (Dordr); 2016 Oct; 39(5):473-481. PubMed ID: 27444787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of avidin/biotin-liposome system for enhanced peritoneal drug delivery in an ovarian cancer model.
    Zavaleta CL; Phillips WT; Soundararajan A; Goins BA
    Int J Pharm; 2007 Jun; 337(1-2):316-28. PubMed ID: 17276633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of OIA ovarian ascitic epithelioma by oxygen-peritoneum combined with a cytostatic drug (triethylene melamine)].
    Rivenzon A; Comişel V; Rivenzon M
    Oncologia; 1965; 19(4):321-5. PubMed ID: 5864379
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytomorphological changes induced by intraperitoneal chemotherapy present important diagnostic pitfalls in peritoneal fluid cytology.
    Mok Y; Nga ME
    Cytopathology; 2017 Aug; 28(4):299-306. PubMed ID: 28387003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early steps in specific tumor cell lysis by sensitized mouse T lymphocytes. I. Resolution and characterization.
    Martz E
    J Immunol; 1975 Jul; 115(1):261-7. PubMed ID: 50350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of polyclonal antibodies in ascitic fluid of mice: technique and applications.
    Overkamp D; Mohammed-Ali S; Cartledge C; Landon J
    J Immunoassay; 1988; 9(1):51-68. PubMed ID: 3283169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.